This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Ligand Pharmaceuticals Inc (LGND)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 97.43M 160.20M 11.64M 12.38M
Receivables 11.68M 13.64M 6.55M 8.94M
Inventories 1.63M 269.00K 1.39M 1.70M
Other Current Assets 860.00K 3.08M 959.00K 0.00
Total Current Assets 215.57M 185.16M 24.88M 23.82M
Property, Plant & Equipment, Gross 3.15M 3.13M 4.74M 5.67M
Accumulated Depreciation & Depletion 2.78M 2.64M 3.87M 4.88M
Property, Plant & Equipment, Net 372.00K 486.00K 867.00K 788.00K
Intangibles 56.90M 55.29M 57.67M 55.91M
Other Non-Current Assets 32.28M 4.86M 9.06M 11.49M
Total Non-Current Assets 318.36M 72.87M 79.83M 80.44M
Liabilities & Shareholder Equity
Total Assets 533.93M 258.03M 104.71M 104.26M
Accounts Payable 4.08M 7.70M 3.95M 5.85M
Short Term Debt 934.00K 2.36M 0.00 0.00
Other Current Liabilities 10.42M 7.12M 8.85M 7.72M
Total Current Liabilities 20.84M 22.78M 28.94M 35.44M
Long Term Debt 205.37M 195.91M 0.00 13.44M
Deferred Income Taxes 0.00 2.79M 1.10M 334.00K
Other Non-Current Liabilities 3.33M 11.21M 25.06M 28.56M
Minority Interest -2.38M -1.13M 0.00 0.00
Total Non-Current Liabilities 208.70M 208.93M 26.16M 42.34M
Total Liabilities 229.54M 231.71M 55.10M 77.78M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 304.39M 26.32M 49.61M 26.48M
Common Par 20.00K 20.00K 21.00K 21.00K
Additional Paid In Capital 701.48M 680.66M 718.02M 751.50M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -402.01M -659.32M -671.34M -682.76M
Treasury Stock 0.00 0.00 0.00 -42.28M
Other Equity Adjustments 4.90M 4.95M 2.91M 0.00
Total Capitalization 509.76M 222.23M 49.61M 39.93M
Total Equity 304.39M 26.32M 49.61M 26.48M
Total Liabilities & Stock Equity 533.93M 258.03M 104.71M 104.26M
Total Common Shares Outstanding 19.95M 19.58M 20.47M 20.16M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 1.12M
Basic Weighted Shares Outstanding 19.79M 20.42M 20.31M 19.85M
Diluted Weighted Shares Outstanding 21.23M 21.43M 20.75M 19.85M
Number of Employees 21 19 20 21
Number of Part-Time Employees 0 0 0 0
LGND News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

LGND Ligand Pharmaceuticals Inc

Chart of LGND

Analysts Ratings for LGND

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 3 3 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET LGND ANALYST REPORT

LGND Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs